Kim Sablich Jazz Pharmaceuticals PLC (JAZZ) insider trading activity

Kim Sablich is EVP, GM of U.S. of Jazz Pharmaceuticals plc. Currently has a direct ownership of 28,478 shares of JAZZ, which is worth approximately $3.52 Million. The most recent transaction as insider was on Jun 05, 2023, when has been sold 2,082 shares (Ordinary Shares) at a price of $129.73 per share, resulting in proceeds of $270,097. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 28.5K

0% 3M change

0% 12M change

Total Value Held $3.52 Million

Kim Sablich Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 05 2023	SELL Sale (or disposition) back to the issuer	$270,097 $129.73 p/Share	2,082 Reduced 6.81%	28,478 Ordinary Shares
Mar 08 2023	SELL Open market or private sale	$421,247 $139.81 p/Share	3,013 Reduced 8.97%	30,560 Ordinary Shares
Mar 05 2023	SELL Payment of exercise price or tax liability	$229,875 $142.78 p/Share	1,610 Reduced 4.58%	33,573 Ordinary Shares
Mar 03 2023	BUY Grant, award, or other acquisition	-	10,429 Added 22.86%	35,183 Ordinary Shares
Jun 07 2022	SELL Open market or private sale	$367,395 $150.51 p/Share	2,441 Reduced 8.98%	24,754 Ordinary Shares
Jun 06 2022	SELL Open market or private sale	$211,184 $152.15 p/Share	1,388 Reduced 4.86%	27,195 Ordinary Shares
Jun 06 2022	SELL Payment of exercise price or tax liability	$262,531 $149.25 p/Share	1,759 Reduced 5.8%	28,583 Ordinary Shares
Mar 05 2022	SELL Payment of exercise price or tax liability	$114,854 $153.96 p/Share	746 Reduced 2.4%	30,342 Ordinary Shares
Mar 03 2022	BUY Grant, award, or other acquisition	-	9,953 Added 24.25%	31,088 Ordinary Shares
Nov 11 2021	SELL Open market or private sale	$371,007 $135.01 p/Share	2,748 Reduced 11.51%	21,135 Ordinary Shares
Jun 05 2021	SELL Payment of exercise price or tax liability	$256,234 $176.47 p/Share	1,452 Reduced 5.73%	23,883 Ordinary Shares
Feb 25 2021	BUY Grant, award, or other acquisition	-	8,535 Added 25.2%	25,335 Ordinary Shares

Also insider at

EIGR

Eiger BioPharmaceuticals, Inc. Healthcare

Kim Sablich

EVP, GM of U.S.

Dublin 4, L2

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JAZZ shares.

Notify only if

Value

Insider Trading

Get notified when an Jazz Pharmaceuticals PLC insider buys or sells JAZZ shares.

Notify only if

Operation

Value

Type

News

Receive news related to Jazz Pharmaceuticals plc

Track Activities on JAZZ

Account